These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 25621782

  • 1. [Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].
    Bettegazzi C, Erra S.
    Recenti Prog Med; 2015 Jan; 106(1):52-7. PubMed ID: 25621782
    [Abstract] [Full Text] [Related]

  • 2. Pathology of gastrointestinal stromal tumors.
    Hirota S, Isozaki K.
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [Abstract] [Full Text] [Related]

  • 3. [Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].
    Emile JF.
    Med Sci (Paris); 2013 Jan; 29(6-7):630-6. PubMed ID: 23859518
    [Abstract] [Full Text] [Related]

  • 4. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].
    Cao H, Wang M.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336
    [Abstract] [Full Text] [Related]

  • 5. [Histology and molecular biology of GIST].
    Emile JF.
    Bull Acad Natl Med; 2012 Mar; 196(4-5):835-44. PubMed ID: 23550446
    [Abstract] [Full Text] [Related]

  • 6. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y.
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [Abstract] [Full Text] [Related]

  • 7. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)].
    Buleje S J, Yábar B A, Guevara-Fujita M, Fujita R.
    Rev Gastroenterol Peru; 2012 Sep; 32(4):394-9. PubMed ID: 23307090
    [Abstract] [Full Text] [Related]

  • 8. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.
    Parkin B, Chugh R.
    Curr Probl Cancer; 2011 Sep; 35(5):245-54. PubMed ID: 22118564
    [No Abstract] [Full Text] [Related]

  • 9. [Gastrointestinal stromal tumors (GIST) - clinical experience and current therapeutical aspects].
    Iarŭmov N, Velev G, Todorov G, Lukanova Ts, Angelov K, Gribnev P, Sokolov M, Toshev S.
    Khirurgiia (Sofiia); 2007 Sep; (4):27-32. PubMed ID: 18443532
    [Abstract] [Full Text] [Related]

  • 10. Inherited predisposition to gastrointestinal stromal tumor.
    Agarwal R, Robson M.
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):1-13, vii. PubMed ID: 19248967
    [Abstract] [Full Text] [Related]

  • 11. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
    Nannini M, Biasco G, Astolfi A, Pantaleo MA.
    J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
    [Abstract] [Full Text] [Related]

  • 12. KIT gene mutations in gastrointestinal stromal tumor.
    Kang W, Zhu C, Yu J, Ye X, Ma Z.
    Front Biosci (Landmark Ed); 2015 Jun 01; 20(6):919-26. PubMed ID: 25961532
    [Abstract] [Full Text] [Related]

  • 13. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
    Demetri GD.
    Semin Oncol; 2001 Oct 01; 28(5 Suppl 17):19-26. PubMed ID: 11740803
    [Abstract] [Full Text] [Related]

  • 14. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
    Miselli FC, Casieri P, Negri T, Orsenigo M, Lagonigro MS, Gronchi A, Fiore M, Casali PG, Bertulli R, Carbone A, Pierotti MA, Tamborini E, Pilotti S.
    Clin Cancer Res; 2007 Apr 15; 13(8):2369-77. PubMed ID: 17438095
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
    Beliakov IS, Anurova OA, Snigur PV, Tsyganova IV, Sel'chuk VIu, Mazurenko NN.
    Vopr Onkol; 2007 Apr 15; 53(6):677-81. PubMed ID: 18416137
    [Abstract] [Full Text] [Related]

  • 17. [Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy].
    Augustináková A, Kodet R.
    Cesk Patol; 2011 Oct 15; 47(4):148-52. PubMed ID: 22145212
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, Wu ZD, Wang YP, Duan XM.
    Scand J Gastroenterol; 2013 Sep 15; 48(9):1055-65. PubMed ID: 23862765
    [Abstract] [Full Text] [Related]

  • 20. Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital.
    Yeh CN, Chen TW, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF.
    Ann Surg Oncol; 2007 Mar 15; 14(3):1123-8. PubMed ID: 17195905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.